This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Debiopharm S.a., Katholieke Universiteit Leuven. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 28 
1 out of 631 
Years Active: 2014
Title: The Innovations of Joke Snoeck
Introduction
Joke Snoeck is a notable inventor based in Renens, Switzerland. He has made significant contributions to the field of medical research, particularly in the area of Hepatitis C Virus (HCV) drug resistance. His work has implications for the development of more effective treatments for this viral infection.
Latest Patents
Joke Snoeck holds a patent for a "Near full-genome assay of HCV drug resistance." This invention relates to assays that characterize genotypic mutations of the Hepatitis C Virus, which show resistance to anti-HCV drugs. His innovative approach aims to enhance the understanding of drug resistance mechanisms, ultimately improving patient outcomes.
Career Highlights
Throughout his career, Joke Snoeck has worked with prominent organizations, including Debiopharm S.A. and Katholieke Universiteit Leuven. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Jean-Maurice Dumont and Sonia Van Dooren. Their collaborative efforts have further advanced the research surrounding HCV and its treatment.
Conclusion
Joke Snoeck's contributions to the field of medical research, particularly through his patent on HCV drug resistance, highlight his role as an innovative inventor. His work continues to influence the development of effective therapies for Hepatitis C.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile